Why AstraZeneca plc, Costain Group PLC And Sirius Minerals PLC Should Lag The FTSE 100 Today

AstraZeneca plc (LON: AZN), Costain Group PLC (LON: COST) and Sirius Minerals PLC (LON: SXX) all slip, on mixed news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Is the FTSE 100 (FTSEINDICES: ^FTSE) going to end the week higher? Well, it was looking good yesterday, but the index of top UK stocks is down 20 points to 6,614 by late afternoon today, so things are not certain yet. Weak reports from some US companies, coupled with this morning’s news from Vodafone that things are still tough in Europe, have not raised optimism.

A number of individual shares are falling, too. Here are three from the various London indices that are on a bit of a slide today:

AstraZeneca

AstraZeneca (LSE: AZN) (NYSE: AZN.US) shares dipped 44p (1.4%) to 3,261p this morning after the company announced the completion of its acquisition of Omthera Pharmaceuticals, the developer of therapies for treating abnormal blood lipid levels. Today’s announcement told us that “the acquisition strengthens AstraZeneca’s late-stage cardiovascular disease pipeline” with Epanova, a fatty acid composition.

AstraZeneca paid $12.70 per share for a total cash cost of $323m, with Omthera shareholders also getting Contingent Value Rights up to the value of $120m dependent on specific targets for Epanova.

Costain

Infrastructure consultant and developer Costain Group (LSE: COST) saw its shares fall 7.6p (2.7%) to 279p, despite announcing a new £34m contract. The firm has been awarded an Early Contractor Involvement contract for a traffic improvement scheme in north Lincolnshire.

Costain shares are up 40% over the past 12 months, though there is fall in earnings per share forecast for the year to December 2013. But even with that, the shares are on a forward P/E of only around 11, with a 4% dividend yield expected.

Sirius Minerals

Things are getting gloomier by the day for Sirius Minerals (LSE: SXX) as details emerge concerning the deferral of the approval decision for the firm’s York Potash project. The big hurdle now appears to be a report prepared for the North York Moors National Park Authority, which questions the demand for polyhalite and the economic benefits claimed for the project.

For its part, Sirius believes that the report ignores some key economic issues and says that it has a number of healthy agreements for the sale of potash around the world. The Sirius share price responded with a 3.5p (16%) fall to 19p today, taking it down 31% since the start of the week.

Finally, reliable dividends can more than compensate for the day-to-day ups and downs of share prices. So how about a company that’s offering a 5% yield and which could be set for some nice share price appreciation too?

It’s the subject of our BRAND-NEW report, “The Motley Fool’s Top Income Share For 2013“, which you can get completely free of charge — but it will only be available for a limited period, so click here to get your copy today.

> Alan does not own any shares mentioned in this article. The Motley Fool has recommended shares in Vodafone.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

3 beaten-down shares to consider buying before the next bull market

Instead of waiting for stocks to start moving higher, Stephen Wright thinks investors should look for shares that might be…

Read more »

Black father and two young daughters dancing at home
Investing Articles

UK investors piled into these S&P 500 stocks during the Liberation Day sell-off…

Our writer wasn't surprised to see AJ Bell investors buying into the S&P 500 earlier this month, though one popular…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

A stunning 10% dividend-yield stock to consider for a Stocks and Shares ISA!

Harvey Jones says Stocks and Shares ISA investors should consider FTSE 250 fund manager aberdeen, a recovery stock that pays…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Here’s why the AstraZeneca share price dipped 3.7% in the FTSE 100 today

Despite AstraZeneca’s falling share price today, this writer believes the London-listed pharmaceutical giant could be worth a closer look.

Read more »

Photo of a man going through financial problems
Investing Articles

I asked ChatGPT to name 3 growth stocks to consider buying in today’s dip. Here they are!

Harvey Jones wants to use the stock market sell-off to buy some great value growth stocks and decided to call…

Read more »

Serious thinking young woman
Investing Articles

Are Associated British Food shares now one of the FTSE 100’s greatest bargains?

Associated British Food (ABF) shares have slumped on news of tough retail conditions. Is the FTSE 100 stock now too…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Putting £450 in the stock market each month could be worth this much in a decade

Jon Smith explains which sectors could offer high growth potential for the coming decade and how to make the stock…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

As H1 results send the Associated British Foods (ABF) share price down 8%, is it time to buy?

This blip in the ABF share price on interim results day might be just the buying opportunity that patient long-term…

Read more »